Lisa’s Story Comic Strips Now in Book Form

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 12
Volume 9
Issue 12

NEW YORK-When Tom Batiuk’s nationally syndicated comic strip Funky Winkerbean began its compelling breast cancer storyline in January 1999, some questioned whether such a serious subject belonged on the funny pages. However, after 2 years of overwhelming support from breast cancer organizations and survivors, “Lisa’ Story” has shown that not even cancer can injure the funnybone.

NEW YORK—When Tom Batiuk’s nationally syndicated comic strip Funky Winkerbean began its compelling breast cancer storyline in January 1999, some questioned whether such a serious subject belonged on the funny pages. However, after 2 years of overwhelming support from breast cancer organizations and survivors, “Lisa’ Story” has shown that not even cancer can injure the funnybone.

Now the “Lisa’s Story” series returns as an inspirational book that approaches the sensitive topic of breast cancer with openness, humor, and tact. Created in partnership with the National Alliance of Breast Cancer Organizations (NABCO) and published by Perigee Books, “Lisa’s Story” is now available in bookstores ($12.95, ISBN: 0-399-52666-8) and can be ordered online at the BookSpot on NABCO’s website www.nabco.org. Mr. Batiuk and King Features will each donate a portion of the proceeds of book sales to NABCO.

The paperback includes the complete comic strip series that follows Mr. Batiuk’s character, Lisa Moore, through all the complex physical, psychological, and social issues that she and her friends and family face when she is diagnosed with the disease. The book also includes comments from survivors who wrote to tell how the comic strip series touched their lives, as well as a comprehensive list of resources for breast cancer patients, survivors, and their families.

Lisa’s Story follows the odyssey of Lisa Moore, a character in the Funky Winkerbean comic strip, through her breast cancer diagnosis and treatment. Lisa’s husband Les is by her side, dealing with the couple’s HMO (DenialCare) and providing support. The strip ends a year after Lisa’s treatment as she decides to undergo breast reconstruction and join a support group.

Recent Videos
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.
Multidisciplinary care can help ensure that treatment planning does not deviate from established guidelines for inflammatory breast cancer management.
Photographic and written documentation can help providers recognize inflammatory breast cancer symptoms across diverse populations.
The use of guideline-concordant care in breast cancer appears to be more common in White populations than Black populations.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content